IVMP联合IVIG比单用IVIG更快提升儿童ITP血小板计数:随机双盲试验结果
Children with immune thrombocytopenia (ITP) rarely suffer from life-threatening bleeds (eg, intracranial hemorrhage). In such settings, the combination of IV methylprednisolone (IVMP) with IV immune globulin (IVIG) is used to rapidly increase platelet counts (PCs).…
要点
- IVMP+IVIG在24小时时平均血小板计数高于单用IVIG,年龄校正后差异有统计学意义。
- 8小时时两组血小板≥20×10^9/L的比例无组间差异。
- 联合治疗未增加严重出血或意外严重不良事件,且IVIG相关头痛更少。
核心结论
- IVIG联合或不联合糖皮质激素均能快速升板,联合IVMP在24小时升板幅度上可能更优。
- 结果支持在危及生命的出血情况下使用IVMP+IVIG。
主要发现
- 治疗开始后8小时,55%的患儿血小板计数≥20×10^9/L,组间无差异。
关键数值与推荐
- IVMP剂量为30 mg/kg,IVIG(Gamunex 10%)剂量为1 g/kg。
- 纳入标准为1-17岁原发性ITP、血小板计数<20×10^9/L且医生决定使用IVIG治疗。
临床怎么用
- 对于需要快速升板的儿童ITP,可考虑IVIG联合IVMP,尤其在危及生命的出血情况下。
- 联合方案未增加严重不良事件,且可能减少IVIG相关头痛。
局限性
- 研究仅纳入血小板<20×10^9/L且医生决定使用IVIG的患儿,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children with immune thrombocytopenia (ITP) rarely suffer from life-threatening bleeds (eg, intracranial hemorrhage). In such settings, the combination of IV methylprednisolone (IVMP) with IV immune globulin (IVIG) is used to rapidly increase platelet counts (PCs). However, there are no controlled data to support using combination therapy over IVIG alone. We conducted a randomized, double-blind, placebo-controlled study to evaluate the rapidity of the PC increment and associated adverse events (AEs) between 2 regimens: A (IV placebo) and B (IVMP 30 mg/kg), both given over 1 hour, followed in both cases by IVIG (Gamunex 10%) 1 g/kg over 2-3 hours in children 1-17 years old with primary ITP and PCs <20 × 109/L in whom physicians had decided to treat with IVIG. Thirty-two children (ages: median, 8 years; range, 1.2-17.5 years) with a mean baseline PC of 9.2 × 109/L participated. Eighteen were randomized to regimen A and 14 to regimen B. By 8 hours after initiating therapy, 55% of all children had a PC ≥20 × 109/L (no group difference). By 24 hours, mean PCs were 76.9 × 109/L (B) vs 55 × 109/L (A) (P = .06; P = .035 when adjusted for intergroup differences in patient ages). No patient experienced severe bleeding/unexpected severe AEs. There were statistically fewer IVIG-related headaches in the group receiving combination therapy (P = .046). Our findings show a rapid response to IVIG with/without steroids and provide evidence to support the use of IVMP+IVIG in life-threatening situations. This trial was registered at www.clinicaltrials.gov as #NCT00376077.
引用
- Carcao M, Silva M, David M, et al. IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. Blood Adv. 2020. PMID: 32282882. doi:10.1182/bloodadvances.2019001343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。